Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth

Cancer

Volumn 77, Issue 8 SUPPL., 1996, Pages 1598-1604

  Doi, Koichi ^a   Akaike, Takaaki ^a   Horie, Hidechika ^a   Noguchi, Youichiro ^a   Fujii, Shigemoto ^a   Beppu, Toru ^a   Ogawa, Michio ^a   Maeda, Hiroshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

dithiocarbamate iron complex; electron paramagnetic resonance; enhanced vascular permeability; nitric oxide; nitric oxide synthase; nitrosyl iron complex; solid tumor pathology

Indexed keywords

DITHIOCARBAMIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD VESSEL PERMEABILITY; CONFERENCE PAPER; ELECTRON SPIN RESONANCE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOLID TUMOR; SOUTHERN BLOTTING; STATISTICAL ANALYSIS; TUMOR GROWTH;

ANIMALS; BASE SEQUENCE; BLOTTING, SOUTHERN; CAPILLARY PERMEABILITY; CELL DIVISION; CHROMIUM RADIOISOTOPES; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED STRAINS; RNA, MESSENGER; SERUM ALBUMIN, BOVINE; TRANSCRIPTION, GENETIC;

EID: 0029998870     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1598::AID-CNCR27>3.0.CO;2-U     Document Type: Conference Paper

References (23)

1. Stuehr DJ, Griffith OW. Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol 1992;65:287-346.
2. Moncada S, Higgs A. The L-agrinine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
3. Maeda H, Akaike T, Yoshida M, Suga M. Multiple functions of nitric oxide in pathophysiology and microbiology: analysis by a new nitric oxide scavenger. J Leukoc Biol 1994;56:588-92.
4. Maeda H, Noguchi Y, Sato K, Akaike T. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res 1994;85:331-4.
5. Bastian NR, Yim C-Y, Hibbs JB Jr., Samlowski WE. Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets. J Biol Chem 1994;269:5127-31.
6. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 1995;55:727-30.
7. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994;54:1352-4.
8. Matsumura Y, Kimura M, Yamamoto T, Maeda H. Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn J Cancer Res 1988;79:1327-34.
9. 3] bradykinin in ascitic fluid from a patient with gastric cancer. J Biol Chem 1988;263:16051-4.
10. •NO through a radical reaction. Biochemistry 1993;32:827-32.
11. Yoshimura T, Fujii S, Yokoyama H, Kamada H. In vivo electron paramagnetic resonance imaging of NO-bound iron complex in a rat head. Chem Lett 1995;309-10.
12. Kubrina LN, Mikoyan VD, Mordvintcev PI, Vanin AF. Iron potentiates bacterial lipopolysaccharide-induced nitric oxide formation in animal organ. Biochim Biophys Acta 1993;1176:240-4.
13. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387-92.
14. Zheng YM, Schäfer MKH, Weihe B, Sheng H, Corisdeo S, Fu ZF, et al. Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase. J Virol 1990;5786-91.
15. Szabó C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994;91:12472-6.
16. Maeda H, Seymour LW, Miyamoto Y. Conjugates of anticancer agents and polymers: advantage of macromolecular therapeutics in vivo. Bioconjugat Chem 1992;3:351-62.
17. Matsumura Y, Maruo K, Kimura M, Yamamoto T, Konno T, Maeda H. Kinin-generating cascade in advanced cancer patients and in vitro study. Jpn J Cancer Res 1991;82:732-41.
18. Ettinghausen SE, Puri RJ, Rosenberg SA. Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice. J Natl Cancer Inst 1988;80:177-87.
19. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harrey VS, Dvorak HF, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascitic fluid. Science 1983;219:983-5.
20. Maeda H, Akaike T, Yoshida M, Sato K, Noguchi Y. A new nitric oxide scavenger, imidazolineoxyl N-oxide derivative, and its effect in pathophysiology and microbiology. In: Koprowski H, Maeda H, editors. The role of nitric oxide in physiology and pathophysiology. Berlin: Springer-Verlag, 1995:37-50.
21. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci 1994;91:4190-4.
22. Lejeune P, Lagadec P, Onier N, Pinard D, Ohshima H, Jeannin JF. Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 1994;152:5077-83.
23. Kennovin GD, Hirst DG, Flitney FW. Oral N-nitro-L-arginine methyl ester (L-NAME) administration slows the growth of malignant tumors in rodents [abstract]. Endothelium 1993; 1:1.